BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Fatty Liver

Below is an extended Fatty Liver research listing. Click here to return to the Fatty Liver main in depth entry.

Recent Publications on Fatty Liver:

Effect of target-directed regulation of uncoupling protein-2 gene expression on ischemia-reperfusion injury of hepatocytes.
The effect of target-directed regulation of the uncoupling protein-2...
Direct Link
11th October, 2008
Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical
[Relationship of liver fat content to insulin resistance and metabolic syndrome] 11th October, 2008
Department of Endocrinology and Metabolism, Zhongshan Hospital Affiliated
Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. 10th October, 2008
Department of Laboratory Medicine and Medical Research Unit, Seinajoki
Bis deficiency results in early lethality with metabolic deterioration and involution of the spleen and thymus.
Bis (Bcl-2 interacting cell death suppressor), also known as Bag3 or...
Direct Link
9th October, 2008
The Catholic University of Korea.
Frequency of abnormalities detected by upper abdominal ultrasound. 9th October, 2008
Health Promotion Center, Bangkok Hospital, Medical Center, Bangkok,
Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease.
Insulin resistance (IR) and obesity may be associated with impaired...
Direct Link
8th October, 2008
Scientific Directorate, "Bambino Gesu" Children's Hospital and Research
The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease.
Insulin resistance is a major feature of type 2 diabetes mellitus, obesity...
Direct Link
8th October, 2008
Department of Endocrinology and Metabolism, Faculty of Medicine, Baskent
Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice.
ELOVL5 is one of seven mammalian fatty acid condensing enzymes involved in...
Direct Link
8th October, 2008
Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients. 7th October, 2008
"Iuliu Hatieganu" University of Medicine and Pharmacy, 3rd Medical Clinic,
Serum Adipocyte Fatty Acid-Binding Protein Levels Are Associated with Non-Alcoholic Fatty Liver Disease in Type 2 Diabetic Patients.
Objective Adipocyte fatty acid-binding protein (A-FABP) is a major...
Direct Link
7th October, 2008
Health Promotion Center, Samsung Seoul Hospita1.
Age- and Ethnic-Specific Elevation of ALT Among Obese Children at Risk for Nonalcoholic Steatohepatitis (NASH): Implications for Screening.
The objectives are to: (1) characterize ethnic-specific differences in...
Direct Link
4th October, 2008
Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study.
ABSTRACT: BACKGROUND: Non alcoholic fatty liver disease (NAFL) consists in...
Direct Link
4th October, 2008
[Hepatitis C and insulin resistance] 4th October, 2008
Service de gastroenterologie et d'hepatologie, HUG, 1211 Geneve 14.
Retinol and alpha-Tocopherol in Morbid Obesity and Nonalcoholic Fatty Liver Disease.
BACKGROUND: We aimed to study serum retinol and alpha-tocopherol in a...
Direct Link
3rd October, 2008
Unit of Obesity Surgery, Department of Endocrinology and Nutrition,
Nonalcoholic fatty liver disease: the potential role of nutritional management.
PURPOSE OF REVIEW: To review available data pertaining to dietary...
Direct Link
2nd October, 2008
Laboratory of Gastroenterology, Universite Catholique de Louvain (UCL),
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional